The Jonathan L. Sessler Fellowship for Emerging Leaders in Bioinorganic and Medicinal Inorganic Chemistry
The Jonathan L. Sessler Fellowship recognizes emerging leaders in bioinorganic and medicinal inorganic chemistry. Sessler Fellows receive an honorarium, an engraved plaque, and registration, travel and housing support for the ACS National Meeting at which they present their research. Fellowship recipients will be recognized as Jonathan L. Sessler Fellows.
The Sessler Fellowship is open to an investigator in his/her first five years of a tenure-track position, or an equivalent research appointment, with accommodation made for family, health or provider leaves, at a United States academic, national lab, or non-profit institution. Fellows will be selected via a nomination and selection process; self-nominations will not be accepted.
To nominate candidates for the Fellowship, nominators must send a single pdf document containing the following elements:
- The nominee’s name, current affiliation, and contact information
- Date of initial employment in current tenure-track position or research appointment
- Explanation of career leave, if any
- A list of no more than 10 of the nominee’s key publications
- A curriculum vitae
- A summary of the nominee’s research achievement as an independent investigator and a description of why he/she should be considered for the Fellowship, a maximum of three pages with at least one-inch margins and a minimum 11 point font size
- Name, affiliation, and contact details of the person making the nomination
The single pdf file should be sent to firstname.lastname@example.org with “Sessler Fellowship Nomination” in the subject line by 5:00 PM EDT on Tuesday, September 15, 2020.
The Jonathan L. Sessler Endowed Fund for Emerging Leaders in Bioinorganic and Medicinal Inorganic Chemistry was established in 2020 to provide recognition to early-career researchers in the bioinorganic and medicinal inorganic chemistry community.
Professor Jonathan L. Sessler is the R.P. Doherty, Jr. – Welch Regents Chair in Chemistry at the University of Texas at Austin. He earned a B.S. degree with highest honors in chemistry from the University of California, Berkeley, and his Ph.D. in chemistry from Stanford University. Professor Sessler joined the faculty at the University of Texas at Austin in 1984. He holds dozens of patents and has published hundreds of research articles. In 1991, he cofounded Pharmacyclics, a company dedicated to developing cancer-fighting drugs.
The Jonathan L. Sessler Endowed Fund for Emerging Leaders in Bioinorganic and Medicinal Inorganic Chemistry was established in 2020. Fellowship recipients will be listed here.